Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-05 09:01 am Unchanged | 13D | THERAVANCE BIOPHARMA INC TBPH | Weiss Asset Management LP | 7,457,060 15.5% | 0 (Unchanged) | View |
| 2024-02-14 4:00 pm Purchase | 13G | THERAVANCE BIOPHARMA INC TBPH | Irenic Capital Management LP | 2,760,948 5.5% | 2,760,948 (New Position) | View |
| 2024-02-13 5:15 pm Sale | 13G | THERAVANCE BIOPHARMA INC TBPH | VANGUARD GROUP INC | 3,489,262 7.01% | -2,069,577 (-37.23%) | View |
| 2024-02-08 4:54 pm Sale | 13G | THERAVANCE BIOPHARMA INC TBPH | BlackRock Inc. BLK | 4,584,596 9.2% | -745,234 (-13.98%) | View |
| 2023-08-14 5:05 pm Unchanged | 13D | THERAVANCE BIOPHARMA INC TBPH | Weiss Asset Management LP | 7,457,060 14.12% | 0 (Unchanged) | View |
| 2023-07-10 4:33 pm Sale | 13G | THERAVANCE BIOPHARMA INC TBPH | BAUPOST GROUP LLC | 7,419,226 12.84% | -4,000,000 (-35.03%) | View |
| 2023-04-12 1:51 pm Unchanged | 13D | THERAVANCE BIOPHARMA INC TBPH | Weiss Asset Management LP | 7,457,060 11.79% | 0 (Unchanged) | View |
| 2023-02-14 5:07 pm Sale | 13G | THERAVANCE BIOPHARMA INC TBPH | ORBIMED ADVISORS LLC | 0 0% | -5,456,780 (Position Closed) | View |
| 2023-02-14 09:58 am Purchase | 13G | THERAVANCE BIOPHARMA INC TBPH | Madison Avenue Partners LP | 7,012,226 10.4% | 364,201 (+5.48%) | View |
| 2023-02-13 4:41 pm Sale | 13G | THERAVANCE BIOPHARMA INC TBPH | BAUPOST GROUP LLC | 11,419,226 16.95% | -3,111,770 (-21.41%) | View |
| 2023-02-10 4:40 pm Purchase | 13G | THERAVANCE BIOPHARMA INC TBPH | BlackRock Inc. BLK | 5,329,830 7.9% | 327,467 (+6.55%) | View |
| 2023-02-10 4:05 pm Unchanged | 13G | THERAVANCE BIOPHARMA INC TBPH | Weiss Asset Management LP | 7,457,060 11.09% | 0 (Unchanged) | View |
| 2023-02-09 11:35 am Sale | 13G | THERAVANCE BIOPHARMA INC TBPH | VANGUARD GROUP INC | 5,558,839 8.25% | -740,984 (-11.76%) | View |
| 2023-01-30 3:06 pm Purchase | 13G | THERAVANCE BIOPHARMA INC TBPH | BARCLAYS PLC BCS | 3,402,767 5.05% | 3,402,767 (New Position) | View |
| 2022-09-20 4:12 pm Sale | 13D | THERAVANCE BIOPHARMA INC TBPH | GSK plc GSK | 0 0% | -9,644,807 (Position Closed) | View |
| 2022-08-03 08:33 am Unchanged | 13D | THERAVANCE BIOPHARMA INC TBPH | GSK plc GSK | 9,644,807 12.7% | 0 (Unchanged) | View |
| 2022-06-16 3:41 pm Purchase | 13G | THERAVANCE BIOPHARMA INC TBPH | Weiss Asset Management LP | 6,157,360 8.09% | 6,157,360 (New Position) | View |
| 2022-04-21 11:08 am Purchase | 13G | THERAVANCE BIOPHARMA INC TBPH | ODRE 2005 SLU | 4,108,318 5.5% | 4,108,318 (New Position) | View |
| 2022-02-14 4:40 pm Sale | 13G | THERAVANCE BIOPHARMA INC TBPH | Point72 Asset Management L.P. | 228,922 0.3% | -4,915,715 (-95.55%) | View |
| 2022-02-14 09:43 am Purchase | 13G | THERAVANCE BIOPHARMA INC TBPH | Madison Avenue Partners LP | 6,648,025 9% | 2,080,612 (+45.55%) | View |